SCHEMBL19080159

SCHEMBL19080159

c1ccc2c(c1)ccc1c2oc2cc(-c3ccc(-c4c5ccccc5c(-c5ccc6oc7ccccc7c6c5)c5ccccc45)cc3)c3ccccc3c21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.37
CDC25A P30304 1/20 0.37
CDC25C P30307 1/20 0.37
CYP1A1 P04798 9/20 0.36
CYP1B1 Q16678 9/20 0.36
ABCB1 P08183 3/20 0.35
ABCC1 P33527 3/20 0.35
ABCG2 Q9UNQ0 3/20 0.35
KDM4E B2RXH2 3/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP1A2 P05177 8/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19076568 0.89 MAPT (0.38) CDC25ACDC25CCYP1A1CYP1B1KDM4E
SCHEMBL19081695 0.89 CYP1A1 (0.40) CYP1A1CYP1B1ABCB1ABCC1ABCG2
SCHEMBL22356432 0.89 CYP1A1 (0.38) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19079985 0.88 CYP1A1 (0.48) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL19079922 0.87 CYP1A1 (0.46) ARSACDC25ACDC25CCYP1A1CYP1B1
SCHEMBL17122576 0.87 CYP1A1 (0.43) CYP1A1CYP1B1ABCB1ABCC1ABCG2
SCHEMBL24469331 0.87 ALOX5 (0.39) CYP1A1CYP1B1ABCB1ABCC1ABCG2
SCHEMBL21687085 0.87 ALOX5 (0.40) CYP1A1CYP1B1ABCB1ABCC1ABCG2
SCHEMBL16067515 0.86 CYP1A1 (0.40) CYP1A1CYP1B1ABCB1ABCC1ABCG2
SCHEMBL27341812 0.86 ALOX5 (0.41) CYP1A1CYP1B1ABCB1ABCC1ABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ARSA 4452/4885CDC25A 44/4885CDC25C 132/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.